Neuralstem, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 13   

Articles published

CUR 2.70 +0.07 (2.66%)
price chart
Imagining the Future Animal
A rabbit�one that stares at the viewer with expressive blue eyes�is engineered for higher intelligence thanks to neural stem cell treatment. None of these species are real yet, and like Fournier's earlier space-age work, they may turn out to be a ...
Will Less SOX2 Lead to Brain Cancer Getting Cold Feet?
PLK1 inhibition suppressed growth, caused G2/M arrest, induced apoptosis and reduced the expression of SOX2, a marker of neural stem cells, in SF188 cells. Consistent with SOX2 inhibition, the loss of PLK1 activity caused the cells to differentiate ...
Watertown people: Undocumented student immigrant shares her story in Time
Keshishyan, who will turn 24 this month, is one of nearly 12 million undocumented immigrants in the United States. Keshishyan, a Watertown resident, was one of several undocumented immigrants who appeared in the June 25 Time cover story �Not Legal ...
R&D Changes Foreseen After Supreme Court Obamacare Decision
Richard Garr, CEO of Neuralstem, told GEN the law will aid drug R&D through its extension of insurance to 32 million more people, and its prohibition on insurers rejecting patients for pre-existing conditions.
Related articles »  
Common Diabetes Drug Found to Stimulate Brain Cell Growth, May Treat ...
They had predicted that metformin might activate the aPKC-CBP pathway in neural stem cells leading to the creation of new neurons, and in the recent series of experiments, they were able to prove that metformin does indeed promotes neurogenesis, both ...
Patients seek stem-cell compensation (blog)
Diabetes drug holds promise in treating brain injuries  National Post
Related articles »  
Newark Biotech Company Awarded $20 Million
... its support," commented Martin McGlynn, President and CEO of StemCells, Inc. "We view this decision by CIRM as a strong vote of confidence in our neural stem cell technology and the world class team of scientists and clinicians who will be ...
Related articles »  
Stem Cells For ALS: Trial Shows Therapy Appears Safe, Well-Tolerated
Neuralstem Updates ALS Stem Cell Trial Progress - Yahoo! Finance · Israel adult stem cell ... Copyright �2014 TheHuffingtonPost.
Positive results from BrainStorm's interim NurOwn stem cell therapy ...
Related articles »  
Optic Nerve Tumors Traced Back To Stem Cells In Young Brains
Researchers at Washington University School of Medicine in St. Louis have traced brain tumors caused by a common genetic disorder back to a particular area in the developing brains of mice, suggesting a possible way of targeting these tumors for ...
Related articles »  
Treating complex spinal pathologies: an interview with Eric Major
In the approximate $8 billion global spine market, the most specialized and demanding $1 billion complex spine segment includes deformity, trauma, and tumor pathologies.
Related articles »  
Global Markets for Stem Cells and Stem Cell Products Expected to Reach $6.6 ...
Hybrid Organ Gmbh 120. Intellicell Biosciences, Inc. 120. International Stem Cell Corporation 121. Juventas Therapeutics, Inc. 122. Medistem Inc. 122. Mesoblast Ltd. 123. Neostem, Inc. 123. Neuralstem 124. Neurogeneration 124. Osiris Therapeutics, Inc.